Search

Your search keyword '"Chan, Bryan K."' showing total 40 results

Search Constraints

Start Over You searched for: Author "Chan, Bryan K." Remove constraint Author: "Chan, Bryan K."
40 results on '"Chan, Bryan K."'

Search Results

2. Discovery of Spiro-azaindoline Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1)

3. Time-resolved spectroscopic studies of the photochemistry of some diphenylgermylene ([Ph.sub.2]Ge:) precursors (1)

5. Discovery of potent azaindazole leucine-rich repeat kinase 2 (LRRK2) inhibitors possessing a key intramolecular hydrogen bond – Part 2

6. Hematopoietic Progenitor Kinase-1 Structure in a Domain-Swapped Dimer

9. Total synthesis of streptonigrone

11. Identification of GNE-293, a potent and selective PI3Kδ inhibitor: Navigating in vitro genotoxicity while improving potency and selectivity

12. Discovery of a Noncovalent, Mutant-Selective Epidermal Growth Factor Receptor Inhibitor

13. Pyridones as Highly Selective, Noncovalent Inhibitors of T790M Double Mutants of EGFR

14. Potent and selective inhibitors of PI3Kδ: Obtaining isoform selectivity from the affinity pocket and tryptophan shelf

15. Effect of selective LRRK2 kinase inhibition on nonhuman primate lung

16. Discovery of Selective and Noncovalent Diaminopyrimidine-Based Inhibitors of Epidermal Growth Factor Receptor Containing the T790M Resistance Mutation

17. Comparative evaluation of 11 in silico models for the prediction of small molecule mutagenicity: role of steric hindrance and electron-withdrawing groups.

18. Discovery of Highly Potent, Selective, and Brain-Penetrant Aminopyrazole Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors

19. Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 Inhibitor

20. Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors

21. Potent and Highly Selective Benzimidazole Inhibitors of PI3-Kinase Delta

22. Discovery of Novel PI3-Kinase δ Specific Inhibitors for the Treatment of Rheumatoid Arthritis: Taming CYP3A4 Time-Dependent Inhibition

23. Discovery of Selective LRRK2 Inhibitors Guided by Computational Analysis and Molecular Modeling

28. Discovery of Selective andNoncovalent Diaminopyrimidine-BasedInhibitors of Epidermal Growth Factor Receptor Containing the T790MResistance Mutation.

31. Discovery of Highly Potent,Selective, and Brain-PenetrantAminopyrazole Leucine-Rich Repeat Kinase 2 (LRRK2) Small MoleculeInhibitors.

33. Discovery of Highly Potent,Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2)Small Molecule Inhibitors.

35. Potent and Highly SelectiveBenzimidazole Inhibitorsof PI3-Kinase Delta.

36. Discovery of Novel PI3-Kinaseδ Specific Inhibitors for the Treatment of Rheumatoid Arthritis:Taming CYP3A4 Time-Dependent Inhibition.

37. Discovery of SelectiveLRRK2 Inhibitors Guided byComputational Analysis and Molecular Modeling.

38. Mild and General One-Pot Reduction and Cyclization of Aromatic and Heteroaromatic 2-Nitroamines to Bicyclic 2H-Imidazoles.

39. Time-resolved spectroscopic studies of the photochemistry of some diphenylgermylene (Ph2Ge:) precursors.

40. Discovery of GNE-6893, a Potent, Selective, Orally Bioavailable Small Molecule Inhibitor of HPK1.

Catalog

Books, media, physical & digital resources